In the Media

BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy

bioRN

BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy

Onco-This-Week

Daiichi Sankyo gins up antibody research project with German research institute

Fierce Biotech

BioMed X Institute launched a new collaboration with Daiichi Sankyo in cancer therapy

Medical Marketing + Media

BioMed X Institute launches new cancer collaboration with Daiichi Sankyo

bionity.com

BioMed X Institute joins forces with Daiichi Sankyo in cancer therapy

The Pharma Letter

Heidelberger BioMed X kooperiert mit Daiichi

transkript

Germany’s BioMed X Institute launches new collaboration with Japanese firm Daiichi Sankyo in cancer therapy

BioSpectrum Asia

BioMedX Launches Collaboration with Daiichi Sankyo to Explore New Approaches in Cancer Treatment

Contract Pharma

BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy

PharmiWeb.com

Collaboration targets multi-specific biologics for solid tumour treatment

Labmate Online

Inside AION Labs, the AI-focused venture studio with the backing of AstraZeneca, Pfizer, AWS and other power players

R&D World

AION Labs Launches New AI Startup to Accelerate Identification of Active Small Molecules for Drug Discovery

PR Newswire

New Immuno-Oncology Research Team in Partnership with Ono Pharmaceutical Starts at BioMed X Institute

Pharmiweb

New Immuno-Oncology Research Team in Partnership with Ono Pharmaceutical Starts at BioMed X Institute

Yahoo Finance

BioMed X Start Collaboration in Autoimmunity Research with Servier

BioSpace

BioMed X Start Collaboration in Autoimmunity Research with Servier

MarketWatch

BioMed X hilft Boehringer und expandiert in die USA

Transkript

Das private Forschungsinstitut BioMed X in Heidelberg meldet erfolgreiche Forschungskooperationen mit der Industrie und expandiert in die USA nach New Haven.

BioMed X Launches New US Institute in New Haven, CT

Newsfile

Connecticut Governor Ned Lamont, New Haven Mayor Justin Elicker, and Josh Geballe, Managing Director of Yale Ventures, participated in the launch ceremony of the new BioMed X Institute on Tuesday, June 11, 2024.

BioMed X Launches New US Institute in New Haven, CT

PharmiWeb

The new institute is managed by Mark Johnston, an experienced biotech CEO and entrepreneur. “We are so grateful for all the local support. New Haven is such a vibrant life sciences hub, coming here was the right choice for us,” explains Johnston.

BioMed X Launches New US Institute in New Haven, CT

BioSpace

Connecticut Governor Ned Lamont, New Haven Mayor Justin Elicker, and Josh Geballe, Managing Director of Yale Ventures, participated in the launch ceremony of the new BioMed X Institute on Tuesday, June 11, 2024.